Ultragenyx Pharmaceutical Overview
Ultragenyx Pharmaceutical Target Price
Analysts' 12-month price predictions for RARE.
Get informed when a big investor buys or sells
+ FollowShare Price
$22.41
Average Target Price
$46.10
105.7% upside
105.7% upside10 analysts in the last 4 months
High: $67 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-08 | Wedbush | $26 | 16% upside |  |
| 2026-05-08 | Guggenheim | $43 | 91.9% upside | |
| 2026-04-29 | BarclaysEliana Merle | $43 | 91.9% upside | |
| 2026-04-16 | Morgan Stanley | $67 | 199% upside | |
| 2026-03-12 | Leerink PartnersJoseph Schwartz | $60 | 167.7% upside | |
| 2026-02-18 | Evercore ISIGavin Clark-Gartner | $34 | 51.7% upside | |
| 2026-02-17 | Evercore ISI | $37 | 65.1% upside | |
| 2026-02-17 | H.C. WainwrightRaghuram Selvaraju | $50 | 123.1% upside | |
| 2026-02-13 | Goldman Sachs | $61 | 172.2% upside | |
| 2026-02-13 | Robert W. Baird | $40 | 78.5% upside | |
| 2026-01-08 | Morgan StanleyMaxwell Skor | $50 | 123.1% upside | |
| 2026-01-05 | H.C. Wainwright | $60 | 167.7% upside | |
| 2026-01-05 | Guggenheim | $52 | 132% upside | |
| 2025-12-30 | Wells FargoBen Burnett | $45 | 100.8% upside | |
| 2025-12-30 | Jefferies | $63 | 181.1% upside | |
| 2025-12-29 | Barclays | $44 | 96.3% upside | |
| 2025-12-29 | Robert W. BairdJoel Beatty | $47 | 109.7% upside | |
| 2025-12-29 | Morgan StanleyJeffrey Hung | $55 | 145.4% upside | |
| 2025-11-24 | BarclaysGena Wang | $50 | 123.1% upside | |
| 2025-03-17 | Piper Sandler | $115 | 413.2% upside | |
| 2025-03-07 | Morgan Stanley | $64 | 185.6% upside | |
| 2024-11-06 | Leerink PartnersJoseph Schwartz | $85 | 279.3% upside | |
| 2024-11-06 | H.C. WainwrightEd Arce | $95 | 323.9% upside | |
| 2024-06-06 | Goldman SachsSalveen Richter | $67 | 199% upside | |
| 2024-05-31 | Stifel NicolausDae Gon Ha | $127 | 466.7% upside | |
| 2024-05-31 | Raymond JamesChristopher Raymond | $135 | 502.4% upside | |
| 2024-05-31 | Robert W. BairdJoel Beatty | $72 | 221.3% upside | |
| 2024-05-31 | Canaccord GenuityWhitney Ijem | $111 | 395.3% upside | |
| 2024-04-15 | Stifel NicolausDae Gon Ha | $124 | 453.3% upside | |
| 2024-04-15 | Raymond JamesChristopher Raymond | $130 | 480.1% upside | |
| 2023-02-03 | Morgan Stanley | $95 | 323.9% upside | |
| 2022-12-30 | H.C. Wainwright | $82 | 265.9% upside | |
| 2022-07-28 | Piper SandlerChristopher Raymond | $130 | 480.1% upside | |
| 2022-07-01 | Stifel Nicolaus | $142 | 533.6% upside | |
| 2022-05-24 | Goldman Sachs | $101 | 350.7% upside | |
| 2022-05-18 | Piper SandlerChristopher Raymond | $135 | 502.4% upside | |
| 2022-05-06 | Morgan Stanley | $109 | 386.4% upside | |
| 2022-05-06 | Leerink Partners | $115 | 413.2% upside | |
| 2022-01-10 | Cowen & Co.Yaron Werber | $124 | 453.3% upside | |
| 2021-11-03 | CitigroupYigal Nochomovitz | $150 | 569.3% upside | |
| 2021-11-03 | WedbushLaura Chico | $92 | 310.5% upside | |
| 2021-09-27 | Piper SandlerChristopher Raymond | $170 | 658.6% upside | |
| 2021-08-19 | UBSEsther Rajavelu | $73 | 225.7% upside | |
| 2021-08-03 | BarclaysGena Wang | $141 | 529.2% upside | |